226916-25-2

Usage

Uses

Used in Pharmaceutical Industry:
(1'R,3'aR,8'aS,9'S,9'aR)-1',3'a,5',7',8',8'a,9',9'a-octahydro-1'-methyl-3'-oxo-spiro[1,3-dioxolane-2,6'(3'H)-naphtho[2,3-c]furan]-9'-carboxylic acid phenylmethyl ester is used as a potential pharmaceutical agent for its possible pharmacological or biological activity. The complex ring system and multiple functional groups in its structure may contribute to its efficacy in treating various medical conditions.
Used in Research and Development:
In the field of organic chemistry and drug discovery, (1'R,3'aR,8'aS,9'S,9'aR)-1',3'a,5',7',8',8'a,9',9'a-octahydro-1'-methyl-3'-oxo-spiro[1,3-dioxolane-2,6'(3'H)-naphtho[2,3-c]furan]-9'-carboxylic acid phenylmethyl ester serves as a subject of research and development. Its unique molecular structure can be studied to understand its properties, reactivity, and potential applications in the synthesis of new compounds with therapeutic or other beneficial uses.

Downstream Products

• 226915-12-4 (1'R,3'aR,4'aR,8'aR,9'S,9'aS)-decahydro-1'-methyl-9'-[(E)-2-[5-[3-(trifluoromethyl)phenyl]-2-pyridinyl]ethenyl]-spiro[1,3-dioxolane-26'(3'H)-naphtho[2,3-c]furan]-3'-one 
• 226916-29-6 (1'R,3'aR,4'aR,8'aR,9'S,9'aS)-decahydro-1'-methyl-3'-oxo-spiro[1,3-dioxolane-2,6'(3'H)-naphtho[2,3-c]furan]-9'-carboxaldehyde 

Relevant academic research and scientific papers

Metabolism-based identification of a potent thrombin receptor antagonist

The metabolism of our prototypical thrombin receptor antagonist 1, K i = 2.7 nM, was studied and three major metabolites (2, 4, and 5) were found. The structures of the metabolites were verified independently by synthesis. Compound 4 was shown